PDT Partners’s BioTelemetry, Inc. BEAT Stock Holding History

PDT Partners’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-92,990	Closed	-$5.82M	–	506
2019 Q1	$5.82M	Sell	92,990 -27,388	-23%	-$1.88M	0.33%	104
2018 Q4	$7.19M	Buy	120,378 +11,878	+11%	+$713K	0.4%	102
2018 Q3	$6.99M	Sell	108,500 -14,000	-11%	-$781K	0.29%	125
2018 Q2	$5.51M	Sell	122,500 -34,800	-22%	-$1.39M	0.21%	152
2018 Q1	$4.88M	Sell	157,300 -654	-0.4%	-$21.5K	0.16%	169
2017 Q4	$4.72M	Buy	+157,954	New	+$4.57M	0.14%	191
2015 Q4	–	Sell	-43,319	Closed	-$530K	–	1273
2015 Q3	$530K	Buy	+43,319	New	+$552K	0.01%	889

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PDT Partners's BEAT Position: Q2 2019 in Review

PDT Partners sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 92,990 shares — an estimated $5.82M sold.

PDT Partners first reported a position in BEAT in Q3 2015 and held it in 7 quarters. The position peaked at $7.19M in Q4 2018. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

PDT Partners reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
PDT Partners sold 92,990 BioTelemetry, Inc. shares in Q2 2019, an estimated $5.82M.
PDT Partners first reported a position in BioTelemetry, Inc. in Q3 2015 and held it in 7 quarters.
PDT Partners's BioTelemetry, Inc. position peaked at $7.19M in Q4 2018.
251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on PDT Partners's 13F filing for Q2 2019, filed 14 Aug 2019.